Abstract
Intraobserver variation of three grading systems—Mostofi, Gleason and Böcking—is examined. No significant difference was noted between the histological grades found in the two examinations by any of the three methods used. Neither the type of surgical procedure nor the number of slices with tumour influenced the reproducibility of histological grading within each system studied. In the Gleason system the intraobserver highest disagreement would not have resulted in change of therapy choice, but in 2% of tumours graded according to the Mostofi system this would have occurred if the choice of therapy would depend on the grading results.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bain, G. O., Koch, M., Hanson, J.: Feasibility of grading prostatic carcinomas.Arch. Pathol. Lab. Med., 106, 265 (1982).
Billis, A.: Graduação histológica do carcinoma da próstata correlação com estadiamento clínico.Br. J. Urol., 9, 88 (1983).
Billis, A., Ferreira, U., Castilho, L. N., Baccili, C.: Carcinoma incidental (estádio A) da próstata em material de patologia cirúrgica. Importância do grau histológico (sistemas Mostofi, Böcking e Gleason) e da extensão tumoral.Br. J. Urol., 14, 84 (1988).
Böcking, A., Kiehn, J., Heinzel-Wach, M.: Combined histologic grading of prostatic carcinoma.Cancer, 50, 288 (1982).
Brumini, R.: Câncer no Brasil: dados histopatológicos. Rio de Janeiro, Ministério da Saúde, Campanha Nacional de Combate ao Câncer, 1982.
Catalona, W. J.: Grading and staging of prostate cancer.J. Urol., 128, 747 (1982).
Denis, L. J.: Clinical cancer of prostate. Influence of tumor stage and grade of five year survival.Acta Urol. Belg., 40, 126 (1972).
Faul, P., Eisenberger, F., Elsässer, E.: Metastatic involvement of pelvic lymph node in relation to the morphological differentiation grade and clinical status of prostatic cancer.Urologe, 24, 326 (1985).
Gaeta, J. F., Englander, L. C., Murphy, G. P.: Comparative evaluation of national prostatic cancer treatment group and Gleason systems for pathologic grading of primary prostatic cancer.Urology, 27, 306 (1986).
Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: M. Tannenbaum (ed.): Urologic Pathology: The Prostate. Lea and Febiger, Philadelphia 1977.
Harada, M., Mostofi, F. K., Corle, D. K., Byar, D. P., Trump, B. F.: Preliminary studies of histological prognosis in cancer of the prostate.Cancer Treat. Rep., 61, 223 (1977).
Henson, D. E.: The histological grading of neoplasm.Arch. Pathol. Lab. Med., 112, 1091 (1988).
Huben, R. P., Murphy, G. P.: Prostate cancer, an update. CA,36, 274 (1986).
Mostofi, F. K.: Grading of prostatic carcinoma.Cancer Chemother. Res., 59, 111 (1975).
Murphy, G. P., Whitmore, W. F. Jr.: A report of the workshops on the current status of the histologic grading of prostate cancer.Cancer, 44, 1490 (1979).
Paulson, D. F., Piserchia, P. V., Gardner, W.: Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study.J. Urol., 123, 697 (1980).
Sogani, P. C., Israel, A., Lieberman, P. H., Lesser, M. L., Whitmore, W. F. Jr.: Gleason grading of prostate cancer: a predictor of survival.Urology, 25, 223 (1985).
Svanholm, H., Mygind, H.: Prostatic carcinoma reproducibility of histologic grading.Acta Pathol. Microbiol. Immunol. Scand., 93, 67 (1985).
Voeth, C., Droese, M., Steuer, G.: Results from cytologic grading of prostatic carcinoma.Urologe, 17, 367 (1978).
Whitmore, W. F. Jr.: The natural history of prostatic cancer.Cancer, 32, 1104 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cintra, M.L., Billis, A. Histologic grading of prostatic adenocarcinoma: Intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems. International Urology and Nephrology 23, 449–454 (1991). https://doi.org/10.1007/BF02583988
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02583988